newsfilter
← Latest News
GlobeNewswire·

Opiant Pharmaceuticals Announces Appointment of Matthew Ruth as Chief Commercial Officer

Mr. Ruth led the highly successful launch and commercialization of the first FDA-approved nasal naloxone spray to treat opioid overdose He joins Opiant at a time when the Company is developing and moving towards potential commercialization of OPNT003,